INDIGO Trial

WALTHAM, Mass., June 2, 2026 Zenas BioPharma, Inc. announced positive results from its registrational Phase 3 INDIGO trial evaluating...

SHANGHAI, China, May 29, 2026 Dizal has announced groundbreaking results from the global Phase 3 WU-KONG28 trial, demonstrating that...

BOSTON, Massachusetts, May 31, 2026 Servier has announced extended follow-up results from the pivotal Phase 3 INDIGO trial, demonstrating...